
Hub service providers look to telehealth to expand patient connectivity

Commercial teams can prepare for overcoming predictable hurdles

Production quotas for controlled substances are being raised by 15%

Now a Danaher Corp. asset, the former GE Healthcare Life Sciences business has been reshuffled

Newly initiated trials may prove value—but even then, supplies may be limited, and hoarding is already occurring

When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies

For sessions with co-workers or clients, consider these recommendations

As of March 26, 71 treatments and 47 vaccines are in development

US list-price sales reached $510 billion in 2019

Passenger-based carriers are repurposing their flights

DEA-registered practitioners can prescribe without an in-person interview

Guidance enables these workers to continue reporting to work

CoverMyMeds report gives evidence of ongoing difficulties in patient support

Copenhagen, Denmark tops Boyd Co.’s list with the highest annual operating costs

But: the growth number of companies is exceeding the growth of trials

The big question is how well will the system respond to spikes in demand, and lack of product



PCMA study disputes its members’ harm to brick-and-mortar businesses

Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market

Level 1-3 serialization with a cloud-based system is up and running in a day

ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data

Clarivate Analytics predicts both approvals and commercial potential

Now two-plus years on, the dispute over physician databases shows no sign of resolution

Deal with Evoke Pharmaceuticals anticipates FDA approval

Europe leads in trial locations

Too many states have opted out of the $18-billion agreement being negotiated in federal court

TCP will now be known as Integreon Global

A former executive at PhRMA, Davis will now lead the wholesaler-distributor association